AFMD: Margin dodolan resik Affimed NV

AFMD (Affimed NV) - tandha merek perusahaan

Sales margin dynamics reflect market expectations for Affimed (AFMD), where 0.00 captures the current value of the indicator. High profitability is sustained by the optimization of component supply chains. Oncology risks are mitigated by the development of therapies for various lymphomas. Simultaneously, Affimed (AFMD) aims to capture market share before major corporate behemoths enter, accelerating its clinical trials.

Affimed N.V. (AFMD) - Margin dodolan perusahaan saka 04.07.2022 nganti 31.05.2025

Rincian analitis perusahaan Affimed

- rega saham lan prakiraan rega para ahli:
- informasi kapitalisasi pasar:
Ringkesan analisis perusahaan:Affimed Therapeutics - AFMD
Barang unggulan Affimed

For Affimed (AFMD), the company's net margin profile reflects the efficiency of converting revenue into bottom-line income. This metric measures the profit share from each unit of product, excluding reporting time lags. The high sensitivity of this indicator reveals the quality of capital management and the risk of overpaying for the asset. For this immunotherapy developer, this is critical: massive clinical costs are replaced by the low cost of mass production. The trend of the curve confirms the business's ability to generate monopoly superprofits.

Analisis pesaing

argenx (ARGX) - Margin resik|BNTX - Margin dodolan perusahaan|ABVX (Abivax Pharma) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ADMA Bio (ADMA)|Rentabilitas dodolan miturut bathi resik PTGX (Protagonist Therapeutics Inc)|Margin dodolan resik immunovant.com (IMVT)|Margin resik kiniksa.com KNSA|Grifols SA (GRFS) - Margin resik|Adaptive Biotechnologies Inc. - Margin dodolan resik|Margin resik Celldex Therapeutics|AUPH: Margin dodolan resik|BCRX - Margin dodolan perusahaan|VERA (Vera Corp) - Margin dodolan resik|Dianthus Pharma (DNTH) - Margin dodolan perusahaan|Margin resik Pharvaris Pharma (PHVS)|Margin dodolan resik AbCellera Corp (ABCL)|Margin dodolan resik TRML (Tourmaline Bio Inc)|Margin dodolan perusahaan precigen.com (PGEN)|PHAR - Margin resik|Tingkat bathi resik NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Rentabilitas dodolan miturut bathi resik|Zenas Corp (ZBIO) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik IMNM|GOSS: Tingkat bathi resik|Margin resik KalVista Pharma (KALV)|SEPN - Margin resik|Margin dodolan resik PVLA (pieris.com)|Margin dodolan resik Savara Pharma SVRA|RIGL: Rentabilitas dodolan miturut bathi resik|ANAB - Margin dodolan resik|ATXS: Margin dodolan resik|ENGN - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RAPT|JBIO (Aerovate Therapeutics Inc) - Rentabilitas resik perusahaan|Margin dodolan resik ACRS|Rentabilitas dodolan miturut bathi resik kyvernatx.com KYTX|Margin dodolan resik TLSA (Tiziana Life Sciences, Ltd.)|Margin dodolan resik Cabaletta Bio CABA|VTYX: Rentabilitas dodolan miturut bathi resik|Theratechnologies Inc. (THTX) - Rentabilitas dodolan miturut bathi resik|AVTX: Margin dodolan resik|ELDN - Margin dodolan perusahaan|AGEN (Agenus, Inc) - Margin dodolan resik|Margin dodolan resik Climb Bio, Inc.|Margin resik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Tingkat bathi resik|Margin dodolan resik ADAG (Adagene Inc)|IMA - Rentabilitas dodolan miturut bathi resik|STTK - Margin resik|EQ (equilliumbio.com) - Rentabilitas dodolan resik|CNTB: Margin dodolan resik|Immunic Inc (IMUX) - Margin dodolan resik|ATRA (Atara Biotherapeutics Inc) - Margin dodolan resik|Rentabilitas dodolan resik IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Tingkat bathi resik|Adicet Bio, Inc. - Rentabilitas dodolan resik|Celularity Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik INmune Bio Corporation INMB|Barinthus Biotherapeutics - Margin dodolan resik|Kezar Life Sciences, Inc. (KZR) - Rentabilitas dodolan miturut bathi resik|SAB Biotherapeutics Inc. (SABS) - Margin resik|Rentabilitas dodolan miturut bathi resik Akari Therapeutics plc|Margin resik enlivex.com|q32bio.com (QTTB) - Margin dodolan perusahaan|Margin dodolan resik GOVX|Edesa Biotech, Inc. - Rentabilitas dodolan resik|iBio Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Carisma Therapeutics CARM|XTLB - Margin resik|BOLT (boltbio.com) - Rentabilitas dodolan resik|HCWB: Margin dodolan resik|Aptevo (APVO) - Margin dodolan resik|Margin resik AIM ImmunoTech|Rentabilitas dodolan miturut bathi resik Aditxt (ADTX)|Rentabilitas dodolan miturut bathi resik GRI (GRI Bio Corporation)|XORTX - Rentabilitas dodolan resik|Margin dodolan resik HIND (Vyome Holdings Inc.)|Tingkat bathi resik REVB|Indaptus - Margin dodolan resik|SCNI (Scinai Immunotherapeutics Ltd.) - Rentabilitas dodolan resik|CALI: Margin dodolan resik|Allakos Therapeutics (ALLK) - Margin dodolan resik|HOOK (HOOKIPA) - Margin dodolan resik|igmbio.com (IGMS) - Margin dodolan perusahaan|Margin dodolan resik ITOS|OCEA (Ocean Biomedical) - Tingkat bathi resik|Margin dodolan resik TCBP (TC BioPharm (Holdings) PLC)|THRD - Rentabilitas dodolan miturut bathi resik